Company / Revenue
ResMed Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$5.1B
FY2025
5-year range
$3.2B / $5.1B
FY2021-FY2025
Trend
+9.8%
vs FY2024
Sector context
#40 of 150
Health Care
What the data says
At $5.1B, ResMed's revenue ranks #40 of 150 in the Health Care sector. Revenue has increased for 9 consecutive years, from $1.8B in FY2016 to $5.1B in FY2025.
Based on SEC 10-K filings.
$5.1B in FY2025 with a 5-year CAGR of +11.7%.
Improved from $4.2B to $5.1B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +12.9%
- 5-Year CAGR
- +11.7%
- 10-Year CAGR
- -
Sector benchmark
#40 of 150 in Health CareTop 27% of 150This company $5.1B Sector average $19.5B
▼
-73.6% below sector average
Key checks
Key Insights
- ResMed's revenue has grown for 9 consecutive years.
- 5-year CAGR of +11.7%, indicating consistent growth.
- In FY2025, revenue increased 9.8% year-over-year.
- Ranks #40 out of 150 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.1B | +9.8% |
| FY2024 | $4.7B | +10.9% |
| FY2023 | $4.2B | +18.0% |
| FY2022 | $3.6B | +11.9% |
| FY2021 | $3.2B | +8.1% |
| FY2020 | $3.0B | +13.4% |
| FY2019 | $2.6B | +11.4% |
| FY2018 | $2.3B | +13.2% |
| FY2017 | $2.1B | +12.4% |
| FY2016 | $1.8B | +9.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026